High-vegetable diet linked to protection against pancreatic cancerSeptember 16, 2005In one of the largest studies of its kind, UCSF researchers have found that eating lots of fruits and vegetables - particularly vegetables - is associated with about a 50 percent reduction in the risk of developing pancreatic cancer. Pancreatic cancer is difficult to diagnose and remains largely untreatable. It kills about 30,000 people in the U.S. each year and has a five-year survival under four percent. The vegetables most strongly associated with increased protection were onions, garlic, beans, yellow vegetables (such as carrots, yams, sweet potatoes, corn and yellow squash), dark leafy vegetables and cruciferous vegetables. Light-green vegetables, tomatoes and tomato products showed weaker protective benefits. Fruits were found to be protective but significantly less so than vegetables, with citrus fruits and citrus juices most protective. The 50 percent reduced risk was associated with eating at last five servings per day of the protective vegetables or vegetables and fruit, compared to those who ate two servings a day or less. And eating nine servings per day of vegetables and fruit combined also was associated with about a 50 percent reduced pancreatic cancer risk compared with eating less than five servings per day. A serving is considered to be about a half cup of cooked vegetables, two cups of leafy salad or one medium-sized piece of fruit. The study was based on in-person interviews of 2,233 San Francisco Bay Area residents: 532 pancreatic cancer patients and more than 1,700 randomly selected "controls." Control group participants did not have pancreatic cancer but were of a similar age distribution and similar male to female ratio as the pancreatic cancer patients. Participants were asked about their fruit and vegetable consumption for the one-year period prior to the interview, as well as other questions about diet, smoking, occupation and other factors. The study findings regarding fruit and vegetable consumption are being published in the September issue of the journal Cancer, Epidemiology, Biomarkers and Prevention. "Pancreatic cancer is not nearly as common as breast or lung cancer, but its diagnosis and treatment are particularly difficult," said Elizabeth A. Holly, PhD, UCSF professor of epidemiology and biostatistics and senior author of the study. "Finding strong confirmation that simple life choices can provide significant protection from pancreatic cancer may be one of the most practical ways to reduce the incidence of this dreadful disease." The results are considered particularly meaningful because of the study's size, the quantitative nature of the food questionnaire and the statistical significance of the findings, according to the study team. The likelihood that chance alone accounts for the discovered correlations between diet and cancer is less than one in a thousand for many vegetable categories, and well within the limits considered statistically significant for most of the vegetables studied, the scientists reported. The findings don't necessarily mean that all fruits and vegetables - or any specific ones - are potentially helpful or harmful, the authors point out. For example, they found evidence that the way foods are prepared may play a role: raw vegetables appear to be somewhat more protective than cooked vegetables, and fried potatoes appear to be more harmful than those prepared other ways. In addition, a specific food could be a "proxy" for another food that is often eaten with it, such as meat eaten with fried potatoes, for a hypothetical example. California physicians are required by law to report all cancer cases to a statewide records center, which allowed the researchers to identify all pancreatic cancer patients treated within a five-year period in six Bay Areas counties: Alameda, Contra Costa, Marin, San Francisco, San Mateo and Santa Clara. The research approach used by the UCSF team is called a "case-control" study because it involves a comparison of pancreatic cancer cases with a control group without pancreatic cancer. The main limitation of this approach is that many of the cancer patients identified at the outset die before they can be interviewed, as was the case with the UCSF study, the researchers reported. Still, the alternative research approach - a "prospective" study that inquires about diet and then follows people long enough to determine which of them contracts the disease - is less feasible because it requires a very large sample size and a very long follow-up period, since pancreatic cancer is relatively rare, Holly said. The authors note that a few prospective cohort studies have published results looking at fruit and vegetable consumption in relation to pancreatic cancer risk, and have observed no association or possibly a slight suggestion of benefit. This may be due, in part, to the reduced number of cancer cases available in such a study design, Holly suggested. "With more follow-up, such studies will be able to examine this question more rigorously," said June M. Chan, ScD, assistant professor of epidemiology and biostatistics at UCSF and lead author of the paper. "In the meantime, results from case-control studies like this one provide support for the hypothesis that vegetables and fruit provide some benefit in protecting against the development of pancreatic cancer." The researchers previously reported on other findings from this in-person interview-based study, namely: allergies, obesity, clinical symptoms of pancreatic cancer and environmental factors in relation to pancreatic cancer; also, genetic factors in relation to pancreatic cancer and cigarette use. Other factors still to be examined in this study are the relationship between pancreatic cancer an alcohol, detailed analyses on cigarette use, diet, other diseases and conditions. University of California-San Francisco |
|||||||||||||||||||||
| Related Pancreatic Cancer Current Events and Pancreatic Cancer News Articles African-Americans with colorectal cancer have poorer outcomes, lower survival rates New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of operation may reduce differences in colorectal cancer outcomes for African-Americans. Discovery offers potential new pancreatic cancer treatment Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer. New research to be presented in November at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Los Angeles reveals that tumor-penetrating microparticles (TPM) have been specifically designed to break through hard-to-infiltrate barriers and deliver drugs more effectively and efficiently than the standard form of chemotherapy such as those injected through a vein. Hepatitis B does not increase risk for pancreatic cancer A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer - and that only age is a contributing factor. M. D. Anderson examines use of toad venom in cancer treatment Huachansu, a Chinese medicine that comes from the dried venom secreted by the skin glands of toads, has tolerable toxicity levels, even at doses eight times those normally administered, and may slow disease progression in some cancer patients, say researchers from The University of Texas M. D. Anderson Cancer Center. Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease. Endothelin-1 inhibitors in chronic pancreatitis Fibrosis is a key feature of chronic pancreatitis and pancreatic cancer. The extensive deposition of extracellular matrix proteins fosters the development of an exocrine and endocrine organ insufficiency, and accelerates progression of the tumour. Autoimmune response can induce pancreatic tumor rejection Immune responses are capable of killing tumors before they can be directed toward normal body tissue, according to new scientific findings published in Cancer Research, a journal of the American Association for Cancer Research. MicroRNAs circulating in blood show promise as biomarkers to detect pancreatic cancer A blood test for small molecules abnormally expressed in pancreatic cancer may be a promising route to early detection of the disease. Blood-flow metabolism mismatch predicts pancreatic tumor aggressiveness Researchers from Turku, Finland, have identified a blood-flow glucose consumption mismatch that predicted pancreatic tumor aggressiveness, according to results of a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. Taking the Needle's Sting Out of Diabetes Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials. More Pancreatic Cancer Current Events and Pancreatic Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||